NCCN 2016 Oncology Fellows Program: New Horizons in Quality Cancer Care™

Hollywood, FL US
April 3, 2016

The purpose of this well-regarded program is to educate future oncology practitioners about the application of the NCCN Clinical Practice Guidelines in Oncology™ and other evidence-based treatment principles in the management of significant cancer types and supportive care issues. The NCCN Oncology Fellows Program has established itself as a premier career-enhancing event for oncology fellows across the United States.

Target Audience

This educational program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.

Learning Objectives

Following this program, participants should be able to:

Advances in Management of Relapsed/Refractory Multiple Myeloma
•    Summarize newly available and emerging treatment options for relapsed/refractory multiple myeloma.
•    Discuss the current treatment strategies and future directions in the management of Waldenström’s macroglobulinemia.

Recurrence Therapy for Ovarian Cancer
•    Outline the specific categories of recurrence therapies for ovarian cancer based on initial patient response to treatment.  
•    Assess recent recommendations for recurrence therapy for patients with ovarian cancer including appropriate dose selection, sequencing, adverse event management, and when to cease therapy.

Surgical Approaches and Systemic Therapies in Management of Kidney Cancer 
•    Summarize the benefits and risks of current surgical and systemic treatment options for patients with renal cell carcinoma to optimize therapeutic outcomes.
•    Evaluate the promising immunotherapy approaches currently being studied in clinical trials.

Recent Advances in Radiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
•    Describe and discuss patient selection criteria for stereotactic ablative radiotherapy (SABR), also known as stereotactic body RT radiotherapy (SBRT) for patients with NSCLC.
•    Apply new radiation therapy recommendations to improve management of patients with NSCLC, including patients with brain metastases. 

Academia or the Community: Selecting the Right Practice Setting for You  
•    Compare and contrast the advantages and disadvantages of community vs. academic oncology practice
•    Identify requirements and formulate strategies for a successful community or academic career

Additional information
Supporters: 

This activity is supported by an educational grants from:

  • AstraZeneca
  • Genentech
  • Takeda Oncology

Supported by an independent educational grant from Merck.

Course summary
Course opens: 
04/01/2016
Course expires: 
09/23/2016
Event starts: 
04/03/2016 - 7:30am
Event ends: 
04/03/2016 - 11:30am
Cost:
$0.00
The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Available Credit

Accreditation Period

Course opens: 
04/01/2016
Course expires: 
09/23/2016

Price

Cost:
$0.00
Please login or register to take this course.